Equity Holdings of Nippon India Pharma Fund
Here is the most recent list of
equity holdings in the Nippon India Pharma Fund's portfolio
as of 30 Apr 2026 . The fund's AUM is 8,365.4 crores, of which equity holdings constitute 98.70%.
| Name of the Equity | Holding Percentage |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 13.85% |
| LUPIN LTD. | 7.95% |
| DIVI'S LABORATORIES LTD. | 6.61% |
| CIPLA LTD. | 5.47% |
| APOLLO HOSPITALS ENTERPRISE LTD. | 5.01% |
| Medplus Health Services Ltd | 3.78% |
| Vijaya Diagnostic Centre Ltd | 3.36% |
| AJANTA PHARMA LTD. | 3.19% |
| Max Healthcare Institute Ltd | 3.16% |
| AUROBINDO PHARMA LTD. | 2.83% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 2.55% |
| IPCA LABORATORIES LTD. | 2.50% |
| ABBOTT INDIA LTD. | 2.26% |
| Thyrocare Technologies Ltd | 2.11% |
| Alkem Laboratories Ltd | 2.09% |
| Dr. Lal PathLabs Ltd | 1.99% |
| PFIZER LTD. | 1.79% |
| Narayana Hrudayalaya Ltd | 1.74% |
| Gland Pharma Ltd | 1.68% |
| Syngene International Ltd | 1.43% |
| FORTIS HEALTHCARE LTD. | 1.22% |
| Sanofi India Ltd | 0.94% |
| BIOCON LTD. | 0.63% |
| ASTRAZENECA PHARMA INDIA LTD. | 0.61% |
| INDOCO REMEDIES LTD. | 0.46% |